Form D Raw Data - Electronic Filing Depository

EFDID: 75486EFD: Raw Data

Issuer: Genesis Biopharma, Inc (0001425205) - D

Accession: 0001513160-13-000035 () (EDGAR Files) (Form D)

Edgar Posted: Jun. 6, 2013
EFD Posted: Aug. 7, 2014

- < edgarSubmission >

< schemaVersion > X0706 </ schemaVersion >

< submissionType > D </ submissionType >

< testOrLive > LIVE </ testOrLive >

- < primaryIssuer >

< cik > 0001425205 </ cik >

< entityName > Genesis Biopharma, Inc </ entityName >

- < issuerAddress >

< street1 > 10960 Wilshire Boulevard </ street1 >

< street2 > Suite 1050 </ street2 >

< city > Los Angeles </ city >

< stateOrCountry > CA </ stateOrCountry >

< stateOrCountryDescription > CALIFORNIA </ stateOrCountryDescription >

< zipCode > 90024 </ zipCode >

</ issuerAddress >

< issuerPhoneNumber > 866-963-2220 </ issuerPhoneNumber >

< jurisdictionOfInc > NEVADA </ jurisdictionOfInc >

- < edgarPreviousNameList >

< previousName > FREIGHT MANAGEMENT CORP </ previousName >

</ edgarPreviousNameList >

< entityType > Corporation </ entityType >

- < yearOfInc >

< overFiveYears > true </ overFiveYears >

</ yearOfInc >

</ primaryIssuer >

- < relatedPersonsList >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Michael </ firstName >

< lastName > Handelman </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 10960 Wilshire Boulevard </ street1 >

< street2 > Suite 1050 </ street2 >

< city > Los Angeles </ city >

< stateOrCountry > CA </ stateOrCountry >

< stateOrCountryDescription > CALIFORNIA </ stateOrCountryDescription >

< zipCode > 90024 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Executive Officer </ relationship >

</ relatedPersonRelationshipList >

< relationshipClarification />

</ relatedPersonInfo >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Paul </ firstName >

< lastName > Kessler </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 10960 Wilshire Boulevard </ street1 >

< street2 > Suite 1050 </ street2 >

< city > Los Angeles </ city >

< stateOrCountry > CA </ stateOrCountry >

< stateOrCountryDescription > CALIFORNIA </ stateOrCountryDescription >

< zipCode > 90024 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

< relationshipClarification />

</ relatedPersonInfo >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > David </ firstName >

< lastName > Voyticky </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 10960 Wilshire Boulevard </ street1 >

< street2 > Suite 1050 </ street2 >

< city > Los Angeles </ city >

< stateOrCountry > CA </ stateOrCountry >

< stateOrCountryDescription > CALIFORNIA </ stateOrCountryDescription >

< zipCode > 90024 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

< relationshipClarification />

</ relatedPersonInfo >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Merrill </ firstName >

< lastName > McPeak </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 123 Furnace Street </ street1 >

< city > Lake Oswego </ city >

< stateOrCountry > OR </ stateOrCountry >

< stateOrCountryDescription > OREGON </ stateOrCountryDescription >

< zipCode > 97034 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Executive Officer </ relationship >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

< relationshipClarification />

</ relatedPersonInfo >

</ relatedPersonsList >

- < offeringData >

- < industryGroup >

< industryGroupType > Biotechnology </ industryGroupType >

</ industryGroup >

- < issuerSize >

< revenueRange > Decline to Disclose </ revenueRange >

</ issuerSize >

- < federalExemptionsExclusions >

< item > 06 </ item >

</ federalExemptionsExclusions >

- < typeOfFiling >

- < newOrAmendment >

< isAmendment > false </ isAmendment >

</ newOrAmendment >

- < dateOfFirstSale >

< value > 2013-05-22 </ value >

</ dateOfFirstSale >

</ typeOfFiling >

- < durationOfOffering >

< moreThanOneYear > false </ moreThanOneYear >

</ durationOfOffering >

- < typesOfSecuritiesOffered >

< isEquityType > true </ isEquityType >

</ typesOfSecuritiesOffered >

- < businessCombinationTransaction >

< isBusinessCombinationTransaction > false </ isBusinessCombinationTransaction >

< clarificationOfResponse />

</ businessCombinationTransaction >

< minimumInvestmentAccepted > 0 </ minimumInvestmentAccepted >

< salesCompensationList />

- < offeringSalesAmounts >

< totalOfferingAmount > 1350000 </ totalOfferingAmount >

< totalAmountSold > 1350000 </ totalAmountSold >

< totalRemaining > 0 </ totalRemaining >

< clarificationOfResponse > $1,350,000 in cash, other consideration in the cancellation of $9,267,640 in debt and the exchange of 12,273,418 warrants. </ clarificationOfResponse >

</ offeringSalesAmounts >

- < investors >

< hasNonAccreditedInvestors > false </ hasNonAccreditedInvestors >

< totalNumberAlreadyInvested > 30 </ totalNumberAlreadyInvested >

</ investors >

- < salesCommissionsFindersFees >

- < salesCommissions >

< dollarAmount > 0 </ dollarAmount >

</ salesCommissions >

- < findersFees >

< dollarAmount > 0 </ dollarAmount >

</ findersFees >

< clarificationOfResponse />

</ salesCommissionsFindersFees >

- < useOfProceeds >

- < grossProceedsUsed >

< dollarAmount > 0 </ dollarAmount >

</ grossProceedsUsed >

< clarificationOfResponse > None, other than compensation to executive officers in their roles as employees. </ clarificationOfResponse >

</ useOfProceeds >

- < signatureBlock >

< authorizedRepresentative > false </ authorizedRepresentative >

- < signature >

< issuerName > Genesis Biopharma, Inc </ issuerName >

< signatureName > /s/ Michael Handelman </ signatureName >

< nameOfSigner > Michael Handelman </ nameOfSigner >

< signatureTitle > Chief Financial Officer </ signatureTitle >

< signatureDate > 2013-06-06 </ signatureDate >

</ signature >

</ signatureBlock >

</ offeringData >

</ edgarSubmission >